{"title":"Crohn's Disease: Diagnosis and Management.","authors":"Brian Veauthier, Jaime Hornecker, Adam Heessel","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Crohn's disease is a chronic inflammatory condition that affects the gastrointestinal tract and often causes extraintestinal manifestations. Diarrhea, abdominal pain, fatigue, weight loss, and fever are common symptoms. Children may present with changes in growth velocity or delayed puberty. Initial evaluation for suspected Crohn's disease includes endoscopy and cross-sectional imaging. Fecal calprotectin testing is useful for determining whether ileocolonoscopy and imaging are needed in uncertain cases. These tests are critical in monitoring treatment effectiveness because mucosal inflammation may remain after symptoms resolve and inflammatory markers normalize. Patients should be tested for iron, 25-hydroxyvitamin D, folate, and vitamin B12 deficiencies. Frequent screening for colon cancer is indicated due to increased colon cancer risk. Most guidelines recommend colonoscopy 8 years after symptom onset, with monitoring dependent on additional risk factors. Treatment is based on disease severity and whether remission is being induced or maintained. Budesonide, sulfasalazine, and dietary modifications should be used to induce remission in mild to moderate disease. Corticosteroids and biologic therapy, with or without immunomodulators, may be used to induce remission of moderate to severe disease. Severe disease is initially treated with intravenous corticosteroids or anti-tumor necrosis factor agents. Perianal and fistulizing disease require treatment of infection, followed by advanced medical therapy and surgical repair.</p>","PeriodicalId":7713,"journal":{"name":"American family physician","volume":"114 2","pages":"139-147"},"PeriodicalIF":3.5000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American family physician","FirstCategoryId":"3","ListUrlMain":"","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Crohn's disease is a chronic inflammatory condition that affects the gastrointestinal tract and often causes extraintestinal manifestations. Diarrhea, abdominal pain, fatigue, weight loss, and fever are common symptoms. Children may present with changes in growth velocity or delayed puberty. Initial evaluation for suspected Crohn's disease includes endoscopy and cross-sectional imaging. Fecal calprotectin testing is useful for determining whether ileocolonoscopy and imaging are needed in uncertain cases. These tests are critical in monitoring treatment effectiveness because mucosal inflammation may remain after symptoms resolve and inflammatory markers normalize. Patients should be tested for iron, 25-hydroxyvitamin D, folate, and vitamin B12 deficiencies. Frequent screening for colon cancer is indicated due to increased colon cancer risk. Most guidelines recommend colonoscopy 8 years after symptom onset, with monitoring dependent on additional risk factors. Treatment is based on disease severity and whether remission is being induced or maintained. Budesonide, sulfasalazine, and dietary modifications should be used to induce remission in mild to moderate disease. Corticosteroids and biologic therapy, with or without immunomodulators, may be used to induce remission of moderate to severe disease. Severe disease is initially treated with intravenous corticosteroids or anti-tumor necrosis factor agents. Perianal and fistulizing disease require treatment of infection, followed by advanced medical therapy and surgical repair.
期刊介绍:
American Family Physician is a semimonthly, editorially independent, peer-reviewed journal of the American Academy of Family Physicians. AFP’s chief objective is to provide high-quality continuing medical education for more than 190,000 family physicians and other primary care clinicians. The editors prefer original articles from experienced clinicians who write succinct, evidence-based, authoritative clinical reviews that will assist family physicians in patient care. AFP considers only manuscripts that are original, have not been published previously, and are not under consideration for publication elsewhere. Articles that demonstrate a family medicine perspective on and approach to a common clinical condition are particularly desirable.